LAG-3 targeting antibodies (North Coast Biologics,)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameLAG-3 targeting antibodies (North Coast Biologics,)
Drug Alias Namelymphocyte activation gene-3 inhibiting antibody (North Coast Biologics)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionLymphocyte activation gene 3 protein inhibitors
TargetsLymphocyte activation gene 3 protein
Therapy Area/Indications +[1]  N/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNorth Coast Biologics LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNorth Coast Biologics LLC
Active IndicationsN/A
Inactive Indications +[1]  N/A

Other Information

ATC CodeN/A
Related LinksN/A